Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Novel Chromatin Modifying Gene Alterations and Significant Survival Association of ATM and P53 in Mantle Cell Lymphoma

Blood (2014) 124 (21): 3033.

https://doi.org/10.1182/blood.V124.21.3033.3033

Published: 2014

Journal Articles

Dose Intensive Induction Followed By Allogeneic Stem Cell Transplantation More Than Doubles Progression-Free and Overall Survival In “Double-Hit” Lymphoma (DHL)

Christina Howlett, PharmD, Andre Goy, MD, Tania Zielonka, Andrew L Pecora, MD, Tatyana Feldman, MD, Scott D Rowley, MD, Michele L. Donato, MD, Mary Timberg, MSN, Gabriella Gadaleta, MSN, David H. Vesole, MD, PhD, Pritish M Bhattacharyya, MD, Kar Fai Chow, MD, Raihan Faroqui, BS, Maria Rosario, Anthony R Mato, MD, MSCE

Blood (2013) 122 (21): 2141.

https://doi.org/10.1182/blood.V122.21.2141.2141

Published: 2013

Journal Articles

Overview Of The Genomic Landscape Of High Risk Diffuse Large B-Cell Lymphoma Using Targeted DNA and RNA Sequencing

Kai Wang, MD PhD, Michelle Nahas, PhD, Anthony R Mato, MD, MSCE, Amy L Donahue, MS, Jie He, PhD, Geoff A Otto, PhD, Doron Lipson, PhD, Roman Yelensky, PhD, Jeff Ross, MD, Phil Stephens, PhD, Kar Fai Chow, MD, Tania Zielonka, Pritish K. Bhattacharyya, MD, Ewelina Protomastro, BS, Tatyana Feldman, MD, Andrew L. Pecora, MD, Vincent Miller, MD, Andre Goy, MD

Blood (2013) 122 (21): 501.

https://doi.org/10.1182/blood.V122.21.501.501

Published: 2013

Journal Articles

Baseline Serum Cytokines Profiles in Mantle Cell Lymphoma Correlates with Outcome

Anthony R Mato, MD, James Greenberg, BS, Mary E Putt, PhD, ScD, K. Stephen Suh, PhD, Yvonne Remache, BA, BSN, Tania Zielonka, RDC, Kathryn Waksmundzki, BS, Ewelina A Protomastro, BA, Susan Stives, APN, Tatyana Feldman, MD, Pritish K. Bhattacharyya, MD, Xiao Yang, M.D. Ph.D, Kar Fai Chow, MD, Alex Campaiola, BSN, Andrew L Pecora, MD, Andre Goy, MD

Blood (2012) 120 (21): 1579.

https://doi.org/10.1182/blood.V120.21.1579.1579

Published: 2012

Journal Articles

Dose-Intensive (R-HCVAD) and High Dose Therapy (ASCT) Frontline Strategies More Than Double PFS Over Standard Therapy in MCL Patients

Anthony R Mato, MD, Ewelina A Protomastro, BA, Tania Zielonka, RDC, Tatyana Feldman, MD, Scott D Rowley, MD, Michele L Donato, MD, Andrew L Pecora, MD, Pritish K. Bhattacharyya, MD, Mary Timberg, RN, MSN, OCN, NP-C, Susan Stives, APN, Gabriella Gadaleta, RN, APN-C, Coleen Bejot, MSN, NP-C, Andre Goy, MD

Blood (2012) 120 (21): 3658.

https://doi.org/10.1182/blood.V120.21.3658.3658

Published: 2012

Journal Articles

Feasibility and Outcome of High Dose Therapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric Population

Anthony R Mato, MD, Andre Goy, MD, Kathryn Waksmundzki, BS, Tatyana Feldman, MD, Tania Zielonka, RDC, Ewelina A Protomastro, BA, Coleen Bejot, MSN, NP-C, Gabriella Gadaleta, RN, APN-C, Scott D Rowley, MD, Michele L Donato, MD, Andrew L Pecora, MD, Katherine Facchin, RN, John P. Leonard, MD, Richard R. Furman, MD, Jia Ruan, MD, PhD, Tsiporah B Shore, Usama Gergis, MD, Morton Coleman, MD, Rebecca Elstrom, MD

Blood (2012) 120 (21): 4269.

https://doi.org/10.1182/blood.V120.21.4269.4269

Published: 2012

Journal Articles

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center.

Anthony R Mato, MD, Kathryn Waksmundzki, BS, Tania Zielonka, RDC, Ewelina A Protomastro, BA, Theresa Amatucci, BS, Maria Rosario, Stuart L. Goldberg, MD, Tatyana Feldman, MD, Scott D Rowley, MD, Michele L. Donato, MD, Mary Timberg, RN, MSN, OCN, NP-C, Melissa F Baker, APN, Pam Sutherland, MSN, CRNP, Phyllis McKiernan, MSN, CRNP, Andrew L Pecora, MD, Andre Goy, MD

Blood (2012) 120 (21): 3120.

https://doi.org/10.1182/blood.V120.21.3120.3120

Published: 2012

Journal Articles

A Decade of Stem Cell Transplantation in Lymphoma: Single Center Experience and Outcome of 938 Consecutive Allogeneic and Autologous Hematopoietic Stem Cell Transplants Performed At John Theurer Cancer Center

Anthony R Mato, MD, Andrew L Pecora, MD, Scott D Rowley, MD, Michele L Donato, MD, Stuart L. Goldberg, MD, Tatyana Feldman, MD, David H. Vesole, MD, PhD, Tania Zielonka, Theresa Amatucci, Alexandria Campaiola, BSN, Arun K Singavi, BS, Clement Cousin, MBBS, Andre Goy, MD

Blood (2011) 118 (21): 3086.

https://doi.org/10.1182/blood.V118.21.3086.3086

Published: 2011

Journal Articles

R-HCVAD/R-MTX-Arac (R-HCVAD) Overcomes Risk Features Associated with Inferior Outcomes In the Treatment of Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma (DLBCL).

Anthony R Mato, MD, Tatyana Feldman, MD, Tania Zielonka, Pritish K. Bhattacharyya, MD, Alexandria Campaiola, BSN, Rina P Shah, BA, Maria Rosario, Coleen Bejot, MSN, Susan Stives, MSN, Mary Curtin, MSN, Rosalba Vicioso, BA, Stuart L Goldberg, MD, Andrew L Pecora, MD, Andre Goy, MD

Blood (2010) 116 (21): 1782.

https://doi.org/10.1182/blood.V116.21.1782.1782

Published: 2010

Journal Articles

Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Treated with R-Hypercvad or ASCT

Anthony R Mato, MD, Tania Zielonka, Tatyana Feldman, MD, Jakub Svoboda, MD, Harry Agress, MD, David Panush, MD, Mitchell Miller, MD, Patrick Toth, MD, Elise A Chong, BA, Emeline R Chong, Drew Torigian, MD, Paul M Lizott, Jr., RT, Stephen J. Schuster, MD, Scott D Rowley, MD, Michele L Donato, MD, Stuart L Goldberg, MD, Andrew L Pecora, MD, Andre Goy, MD

Blood (2010) 116 (21): 3131.

https://doi.org/10.1182/blood.V116.21.3131.3131

Published: 2010

NARROW

Novel Chromatin Modifying Gene Alterations and Significant Survival Association of ATM and P53 in Mantle Cell Lymphoma

Dose Intensive Induction Followed By Allogeneic Stem Cell Transplantation More Than Doubles Progression-Free and Overall Survival In “Double-Hit” Lymphoma (DHL)

Overview Of The Genomic Landscape Of High Risk Diffuse Large B-Cell Lymphoma Using Targeted DNA and RNA Sequencing

Baseline Serum Cytokines Profiles in Mantle Cell Lymphoma Correlates with Outcome

Dose-Intensive (R-HCVAD) and High Dose Therapy (ASCT) Frontline Strategies More Than Double PFS Over Standard Therapy in MCL Patients

Feasibility and Outcome of High Dose Therapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric Population

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center.

A Decade of Stem Cell Transplantation in Lymphoma: Single Center Experience and Outcome of 938 Consecutive Allogeneic and Autologous Hematopoietic Stem Cell Transplants Performed At John Theurer Cancer Center

R-HCVAD/R-MTX-Arac (R-HCVAD) Overcomes Risk Features Associated with Inferior Outcomes In the Treatment of Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma (DLBCL).

Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Treated with R-Hypercvad or ASCT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only